top of page
AI pixabay huge.jpg

People more likely to take part in trials that use decentralized tech

Cancer patients are more likely to take part in clinical trials that use decentralized technologies, according to analysis by U.S. researchers.


The survey, conducted by American Cancer Society Cancer Action Network (ACS/CAN) researchers, looked at the impact “decentralization tools”—wearable and self-report systems, online portals, etc.—have on patient participation in drug trials.



Comments


bottom of page